November 22, 2016 - By Louis Casey · 0 Comments
Nov 22 is a positive day so far for Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD) as the ETF is active during the day after gaining 7.9% to hit $15.44 per share. The exchange traded fund has 66.71M net assets and 9.79% volatility this month.
Over the course of the day 937,825 shares traded hands, as compared to an average volume of 3.54 million over the last 30 days for Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD).
The ETF is -85.89% of its 52-Week High and 3.54% of its low, and is currently having ATR of 2.56. This year’s performance is -52.98% while this quarter’s performance is -31.36%.
The ETF’s YTD performance is -12%, the 1 year is -33.58% and the 3 year is NaN%.
The fund’s top holdings are: S&P Biotechnology Select for 37.11% of assets, Fidelity Institutional Go for 0.00%.
More notable recent Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA:LABD) news were published by: Marketwatch.com which released: “Direxion Daily S&P Biotech Bear 3X Shares” on March 08, 2014, also Quotes.Wsj.com with their article: “DOW JONES, A NEWS CORP COMPANY” published on May 29, 2015, Etftrends.com published: “Triple-Leveraged Biotech ETFs Could be Coming Soon” on March 20, 2015. More interesting news about Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA:LABD) were released by: Investorplace.com and their article: “Be Careful Before Loving Leveraged Biotech ETFs” published on October 06, 2015 as well as Marketwatch.com‘s news article titled: “/quotes/zigman/3870025/realtime” with publication date: July 19, 2013.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Louis Casey